Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”On 17 November, I had the pleasure of taking part in the EAS Lipoprotein(a) Workshop, organized by the European Atherosclerosis Society with the support of Novartis and Fondazione SISA.
It was a highly stimulating opportunity to share experiences on the role of Lp(a) in cardiovascular risk and to further strengthen collaboration within the Lp(a)CCELERATE study.
I left the meeting with clearer ideas, fresh perspectives and – above all – the feeling of being part of a community of colleagues genuinely committed to improving CvPrev
Many thanks to the organizers and to all participants for their questions, insights and openness in building the next steps of this journey together.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 15:33Peter Zdziarski: Will Glanzmann Thrombasthenia Patients Be Formally Recognized as Benefiting from SevenFACT?
-
Apr 15, 2026, 15:20Sonal Sonu: Blood Donation Myths in Rural Areas
-
Apr 15, 2026, 15:01Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 14:55Donald Correll: Key Risk Factors for Venous Thromboembolism
-
Apr 15, 2026, 14:48Fadwa Said Abdelazim: Is Vaping Really ‘Safer’ for the Blood Than Smoking?
-
Apr 15, 2026, 14:42Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
-
Apr 15, 2026, 14:42Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
-
Apr 15, 2026, 14:39Pooja Choradia: Recognizing Pulmonary Embolism in Pregnancy Before It Is Too Late
-
Apr 15, 2026, 14:38Alessandra Bosch։ Understanding Haemostasis in Children and Its Challenges